Showing results (61-70 of 118) with videos related to
Sort By:
Pageof 12
Mechanisms of Development|June 8, 2000
SOX8 expression during chick embryogenesisK M Bell, P S Western, A H SinclairClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 1994
Primary juvenile fibromyalgia syndrome and chronic fatigue syndrome in adolescentsD S Bell, K M Bell, P R CheneyMolecular Pharmacology|September 22, 2000
The steroid 17alpha-acetoxy-6-dimethylaminomethyl-21-fluoro-3-ethoxy-pregna-3, 5-dien-20-one (SC17599) is a selective mu-opioid agonist: implications for the mu-opioid pharmacophoreI J McFadyen, H Houshyar, L Y Liu-Chen, et al.Acta Oncologica (Stockholm, Sweden)|January 1, 1995
The influence of nitric oxide on tumour vascular toneG M Tozer, V E Prise, K M BellEuropean Journal of Pharmacology|May 24, 2000
Activation of G protein by opioid receptors: role of receptor number and G-protein concentrationA E Remmers, M J Clark, A Alt, et al.Acta Neurologica Scandinavica. Supplementum|January 1, 1994
S-adenosylmethionine blood levels in major depression: changes with drug treatmentK M Bell, S G Potkin, D Carreon, et al.Neuroscience Letters|July 13, 2000
Characterization of ZFOR1, a putative delta-opioid receptor from the teleost zebrafish (Danio rerio)R E Rodriguez, A Barrallo, F Garcia-Malvar, et al.The American Journal of Psychiatry|September 1, 1988
S-adenosylmethionine treatment of depression: a controlled clinical trialK M Bell, L Plon, W E Bunney, et al.The Journal of Pharmacology and Experimental Therapeutics|August 16, 2001
GR89,696: a potent kappa-opioid agonist with subtype selectivity in rhesus monkeysE R Butelman, M C Ko, J R Traynor, et al.The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999
kappa-Opioid receptor effects of butorphanol in rhesus monkeysJ A Vivian, M B DeYoung, T L Sumpter, et al.Pageof 12